101. Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis
- Author
-
Marc H. De Baets, Mario Losen, Niels Hellings, Annelies Vanheel, Alejandro M. Gomez, Jean-Paul Noben, Pilar Martinez-Martinez, Peter C. M. Molenaar, Promovendi MHN, Psychiatrie & Neuropsychologie, RS: MHeNs - R3 - Neuroscience, and RS: MHeNs School for Mental Health and Neuroscience
- Subjects
Proteomics ,Immunology ,Neuromuscular transmission ,Autoimmunity ,Muscle proteomics ,medicine ,Immunology and Allergy ,Animals ,Muscle, Skeletal ,Myasthenia gravis ,Acetylcholine receptor ,Autoimmune disease ,Proteomic Profile ,business.industry ,Autoantibody ,Muscle weakness ,medicine.disease ,Myasthenia Gravis, Autoimmune, Experimental ,Rats ,Neurology ,Rats, Inbred Lew ,Disease Progression ,2D-DIGE ,Female ,Neurology (clinical) ,Inclusion body myositis ,medicine.symptom ,business - Abstract
Myasthenia gravis (MG) is an autoimmune disease in which autoantibodies, most commonly directed against the acetylcholine receptor (AChR), impair neuromuscular transmission and cause muscle weakness. In this study, we utilized two-dimensional difference in-gel electrophoresis (2D-DIGE) to analyze the muscle's proteomic profile at different stages of experimental autoimmune myasthenia gravis (EAMG). We identified twenty-two differentially expressed proteins, mainly related to metabolic and stress-response pathways. Interestingly, these identified proteins have also been associated with other contraction-impairing muscle pathologies (e.g. inclusion body myositis), suggesting a similar response of the muscle to such conditions.
- Published
- 2013